Medtor LLC, a Manhattan Beach, CA-based technology company provides a breakthrough in Vital Signs monitoring. The company’s patented White Light Spectral Sensor technology delivers the most accurate heart rate and blood oxygen reading available, filtering out motion and other interfering factors.
Medtor’s wearable device SafeSAT® collects accurate real-time physiological data even on highly active subjects during normal day-to-day activities and while exercising.
Medtor, who will be exhibiting at our WT | Wearable Technologies Show MEDICA 2018, has developed a complete medical OEM solution, including wired sensors and hardware module, which has been validated in several independent clinical studies and is pending FDA clearance, says a press release.
Huge Potential for Product Development
Medtor is currently focusing on completion of an OEM single-patient use, wireless wearable medical biosensor, as well as a wrist wearable module for use in smart-watches and monitors.
Designed for clinical grade mobile, the Medtor vital sign technology clears the way for broader applications in product development and marketing for medical and consumer applications.
SafeSAT® collects accurate real-time physiological data even on highly active subjects during normal day-to-day activities and while exercising.
The fitness tracker that can measure blood oxygen saturation (SpO2) accurately. It also accurately detects potential sleep apnea related events.
This is the “most accurate fitness tracking technology for measuring heart rate, during daily activities. Clinically proven to decrease erratic and inaccurate readings even when exercising, running or biking,” says the company.
The company is actively looking for strategic partners for further developing and marketing its vital sign technology. More info at www.medtorllc.com or email: [email protected]
Medtor booth is located at A23, Hall 15 in the Wearable Section at Medica.